Fan J, Luo W, Fourkal E, Lin T, Li J, Veltchev I, Ma C-M
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Phys Med Biol. 2007 Jul 7;52(13):3913-30. doi: 10.1088/0031-9155/52/13/017. Epub 2007 Jun 6.
In this paper, we present the shielding analysis to determine the necessary neutron and photon shielding for a laser-accelerated proton therapy system. Laser-accelerated protons coming out of a solid high-density target have broad energy and angular spectra leading to dose distributions that cannot be directly used for therapeutic applications. A special particle selection and collimation device is needed to generate desired proton beams for energy- and intensity-modulated proton therapy. A great number of unwanted protons and even more electrons as a side-product of laser acceleration have to be stopped by collimation devices and shielding walls, posing a challenge in radiation shielding. Parameters of primary particles resulting from the laser-target interaction have been investigated by particle-in-cell simulations, which predicted energy spectra with 300 MeV maximum energy for protons and 270 MeV for electrons at a laser intensity of 2 x 10(21) W cm(-2). Monte Carlo simulations using FLUKA have been performed to design the collimators and shielding walls inside the treatment gantry, which consist of stainless steel, tungsten, polyethylene and lead. A composite primary collimator was designed to effectively reduce high-energy neutron production since their highly penetrating nature makes shielding very difficult. The necessary shielding for the treatment gantry was carefully studied to meet the criteria of head leakage <0.1% of therapeutic absorbed dose. A layer of polyethylene enclosing the whole particle selection and collimation device was used to shield neutrons and an outer layer of lead was used to reduce photon dose from neutron capture and electron bremsstrahlung. It is shown that the two-layer shielding design with 10-12 cm thick polyethylene and 4 cm thick lead can effectively absorb the unwanted particles to meet the shielding requirements.
在本文中,我们进行了屏蔽分析,以确定激光加速质子治疗系统所需的中子和光子屏蔽。从固体高密度靶中出射的激光加速质子具有较宽的能量和角谱,导致剂量分布不能直接用于治疗应用。需要一种特殊的粒子选择和准直装置来产生用于能量和强度调制质子治疗的所需质子束。大量不需要的质子以及作为激光加速副产品产生的更多电子必须通过准直装置和屏蔽墙来阻挡,这对辐射屏蔽构成了挑战。通过粒子模拟研究了激光与靶相互作用产生的初级粒子参数,模拟预测在激光强度为2×10²¹W/cm²时,质子的最大能量谱为300 MeV,电子的最大能量谱为270 MeV。使用FLUKA进行了蒙特卡罗模拟,以设计治疗机架内部的准直器和屏蔽墙,这些部件由不锈钢、钨、聚乙烯和铅组成。设计了一种复合初级准直器,以有效减少高能中子的产生,因为它们的高穿透性使得屏蔽非常困难。仔细研究了治疗机架所需的屏蔽,以满足头部泄漏小于治疗吸收剂量0.1%的标准。使用一层聚乙烯包裹整个粒子选择和准直装置来屏蔽中子,并使用一层外层铅来减少中子俘获和电子轫致辐射产生的光子剂量。结果表明,采用10 - 12厘米厚的聚乙烯和4厘米厚的铅的双层屏蔽设计可以有效吸收不需要的粒子,满足屏蔽要求。